Ms. Santhi Uppalapati is the Vice President at IPSA, where she plays a pivotal role in the establishment of policies and procedures while contributing to the development of an ERP system for Novadigm Hospitals. Her responsibilities include the creation of strategic relationships and effective program management.
With a wealth of experience, Ms. Uppalapati has served Fortune 500 clients, including notable companies such as Aurobindo Pharma, Puma Biotech, Dendrion Corp, Adidas, Yamaha Corp of America, and DJO Global, a renowned medical device company.
Her expertise and contributions have been instrumental in the success and growth of IPSA, where she continues to make significant contributions to the organization's strategic objectives.
Dr. Ravishankar Polisetty is a distinguished professional with a diverse background in medicine, research, and healthcare leadership. He is a Cardiovascular Surgeon by training, having completed his education at the Bakoulev Scientific Center of Cardiovascular Surgery in 2008. Dr. Polisetty holds a wide range of qualifications, including an MD in General Medicine, Ordinatura in General, Laparoscopic, and Laser Surgery, Ordinatura in Cardiovascular Surgery, and Aspirantura leading to a PhD in Cardiovascular Surgery. He is also a Doctor of Naturopathy (ND) in India and holds an MD in Alternative Medicine, a Doctor of Natural Medicine (DNM) in Canada, and a DHS (Doctor of Health Science) from Canada. Dr. Polisetty is also trained as a Watson Data Scientist and a Python Programmer.
He has held various significant roles in the healthcare and research sectors, including serving as the CEO and Director of R&D at Sai Ganga Panakeia Pvt Ltd. Dr. Polisetty has also contributed his expertise as a Research Consultant in Intellectual Property at Johns Hopkins University in Baltimore, Maryland, USA. He has led departments in Cardiology and Immunology at the ANO Research Institute for Immunopathology, Moscow Medical Academy, Russia.
In addition to his work in Russia, Dr. Polisetty is the Founder and CEO of Novadigm Health Inc. in the USA. He has also served as the Director of R&D at Panacea Contract Research Consulting in Toronto, Ontario, Canada. Dr. Polisetty has extensive experience as a Senior Consultant in Cardiovascular Surgery at OOO MANI in Moscow.
His contributions extend globally, as he has worked as a Former Clinical Trial Coordinator at Arbor Surgicals in Irvine, California, USA, and as a Former Medical Adviser at Speed Well Being, affiliated with Green Templeton College at the University of Oxford, UK.
Dr. Polisetty's remarkable career has earned him recognition and accolades, including a memento presented by His Excellency, the Former President of India, and the renowned Father of Indian Nuclear Science, Dr. APJ Abdul Kalam. This recognition was bestowed upon him by The Lead India Organizers, a group known for revolutionizing India's education system. Dr. Polisetty's multifaceted background, diverse expertise, and dedication to healthcare and research make him a distinguished figure in the field.
Mr. Duvvuri Sastry serves as the Director at IPSA where he has played a pivotal role in leading the evolution of the herb manufacturing process essential for Novadigm Hospitals. With 25 years of experience, he brings a wealth of expertise in strategic alliances and vendor management to the organization.
Mr. Sastry's extensive career includes over two decades of contributions to Dr. Reddy's Laboratories, where he held the position of Zonal Head for Formulation Marketing. His valuable experience and strategic insights continue to drive advancements and success in his role at IPSA, making him an essential asset to the organization.
Dr. Alex Hankey holds the distinguished position of Professor of Yoga and Physical Science at Swami Vivekananda Yoga Anusandhana Samsthana. He is renowned for his exceptional academic background, which includes earning top degrees from prestigious institutions such as Cambridge and MIT.
As a Lindemann Post-Doctoral fellow at Stanford, where he worked alongside luminaries like Steven Weinberg and Gene Stanley, Dr. Hankey made significant contributions to the field. His expertise extends to the Vedic Sciences and their relationship to modern science. Dr. Hankey has developed a comprehensive program titled 'Decoding Vedic Sciences,' encompassing disciplines such as Ayurveda, Samkhya, Yoga, Vedanta, Jyotish, and aspects of Vyakaran, in addition to Veda.
Within the IPSA, Dr. Hankey serves as a Fundamental Research Advisory Board Member. His vast knowledge and experience make him an invaluable asset, contributing to the organization's research and academic endeavors.
Dr. Carlos V. Rizzo holds the prestigious position of President at Preventinvest Corp. He is a physicist with a deep involvement in various medical projects across Asia, America, and Europe. His primary focus has been on introducing innovative devices and concepts aimed at the proper diagnosis, analysis, and treatment of neurological conditions.
Dr. Rizzo's career has been marked by the fascinating challenge of integrating new technologies, including blockchain technology, with research and development, healthcare, and medical devices to create global solutions. He has been an integral part of the Swiss think tank 'Smartillions,' where he served as the VP of Market Research. His journey continued as he joined Preventinvest, where he ensures the establishment of the ideal ecosystem for synergies within the group of companies.
Within the IPSA, Dr. Rizzo holds the role of Fundamental Research and Business Advisory Board Member. His diverse expertise and commitment make him a valuable contributor to the organization's research and business endeavors.
Dr. Asha Kuppachi holds the esteemed title of Assistant Professor at Texas Woman's University in Dallas, USA. She is a cognitive neuroscientist and an occupational therapist by profession. Dr. Kuppachi's research and teaching endeavors revolve around the integration of cognitive neuroscience principles into cognitive rehabilitation programs, particularly for populations dealing with brain injuries.
Within the IPSA, Dr. Kuppachi plays a vital role as a member of the Clinical and Fundamental Research Board. Her expertise and commitment are instrumental in advancing the organization's clinical and research initiatives, making her a valuable asset to the team.
Dr. Deepak K Barot holds the distinguished position of Vice President of Preclinical Research at Microtherapeutics Research Labs. He brings with him extensive experience in drug discovery research, with a specific focus on metabolic disorders, inflammation, and oncology.
Dr. Barot's expertise spans across various facets of drug metabolism, pharmacokinetics, pharmacology, and toxicology. He has been involved in all aspects of drug discovery, from early-phase drug discovery to lead optimization, and preclinical pharmacokinetic, pharmacology, and toxicology studies. His work primarily revolves around the discovery of New Chemical Entities (NCEs).
Within the IPSA, Dr. Barot serves as a Fundamental Research Advisory Board Member. His wealth of experience and contributions are instrumental in advancing the organization's research initiatives, making him a valuable member of the team.
Mr. Bharat Ramaka is a highly qualified and accomplished SAP HANA Migration Infrastructure Architect, currently serving as a Principal Consultant at Infosys. With extensive expertise in various technologies, his knowledge encompasses a wide range of areas, including: SAP Cloud Computing ; Enterprise Architecture and Application Platforms
Infrastructure ; SAP HANA ; Design and Strategy.
Within the IPSA, Mr. Ramaka contributes as a Business Advisory Board Member. His in-depth technical knowledge and strategic insights make him an invaluable member of the business advisory team, offering valuable guidance to the organization's endeavors.
